NASDAQ:VRDN
Viridian Therapeutics
- Stock
Last Close
27.50
06/11 21:02
Market Cap
783.10M
Beta: 0.98
Volume Today
582.91K
Avg: 548.41K
PE Ratio
−3.84
PFCF: −5.44
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 267.82K - | 183K 31.67% | 125.50K 31.42% | 32K 74.50% | -3.31M - | -3.31M 0% | |||||
average payables | 332.65K - | 248.50K 25.30% | 200.50K 19.32% | 532.50K 165.59% | 738.50K 38.69% | 833.50K 12.86% | 883K 5.94% | 1.50M 69.82% | 8.28M 452.28% | 8.24M 0.54% | |
average receivables | 1.04M - | 741K 28.82% | 459K 38.06% | 990K 115.69% | 740K 25.25% | 66K 91.08% | 54K 18.18% | 225.50K 317.59% | 276.50K 22.62% | 51K 81.56% | |
book value per share | 597.55 - | 289.46 51.56% | -6.78 102.34% | 30.02 542.82% | 26.02 13.32% | 7.54 71.02% | 33.75 347.50% | 15.75 53.33% | 12.31 21.83% | 0.01 99.92% | |
capex per share | -26.53 - | -3.42 87.11% | -0.06 98.18% | -0.19 207.39% | -0.23 17.61% | -0.04 82.17% | -0.01 70.63% | -0.03 140.18% | -0.02 12.41% | -0.00 99.92% | |
capex to depreciation | -1.85 - | -0.67 63.81% | -0.02 97.63% | -0.80 4,931.82% | -1.58 98.28% | -0.29 81.58% | -0.18 39.75% | -2.82 1,502.82% | -3.13 10.96% | 0.08 102.57% | |
capex to operating cash flow | 0.12 - | 0.02 85.17% | 0.00 97.67% | 0.01 2,005.09% | 0.02 89.81% | 0.00 85.95% | 0.00 39.46% | 0.01 339.07% | 0.01 37.15% | 0.00 42.59% | |
capex to revenue | -0.06 - | -0.05 21.29% | -0.00 98.14% | -0.06 6,735.72% | -0.05 13.65% | -0.02 64.52% | -0.04 112.43% | -0.11 185.18% | -0.45 294.28% | -2.86 535.85% | |
cash per share | 510.57 - | 301.19 41.01% | 69.47 76.94% | 36.98 46.77% | 31.66 14.37% | 12.85 59.42% | 35.88 179.25% | 16.53 53.95% | 13.23 19.94% | 0.01 99.92% | |
days of inventory on hand | 20.15 - | 27.61 37.05% | 9.17 66.80% | ||||||||
days payables outstanding | 28.70 - | 35.73 24.50% | 22.78 36.26% | ||||||||
days sales outstanding | 91.93 - | 56.66 38.36% | 57.31 1.15% | 132.76 131.63% | 1.04 99.21% | 8.84 745.93% | 55.56 - | 21.01 62.18% | |||
debt to assets | 0.01 - | 0.09 765.98% | 0.25 186.49% | 0.19 22.95% | 0.16 17.65% | 0.27 76.26% | 0.00 98.74% | 0.00 26.36% | 0.01 373.42% | 0.04 240.92% | |
debt to equity | 0.01 - | 0.11 694.92% | -3.21 3,119.86% | 0.26 108.04% | 0.20 22.15% | 0.53 162.80% | 0.00 99.28% | 0.00 26.92% | 0.01 380.45% | 0.05 243.45% | |
dividend yield | |||||||||||
earnings yield | -1.38 - | -1.87 35.92% | -3.51 87.37% | -0.13 96.23% | -0.36 176.06% | -2.82 673.45% | -1.90 32.75% | -0.34 82.23% | -0.13 60.29% | -0.00 99.82% | |
enterprise value | 690.86K - | -3.67M 631.84% | 1.32M 135.88% | 163.20M 12,280.16% | 67.38M 58.71% | -1.50M 102.23% | 13.07M 971.19% | 193.85M 1,383.00% | 786.95M 305.95% | 974.69B 123,757.05% | |
enterprise value over ebitda | -0.10 - | 0.33 429.80% | -0.14 141.62% | -6.25 4,394.08% | -2.12 66.11% | 0.04 101.73% | -0.32 986.13% | -2.44 654.61% | -6.08 148.77% | -3.83K 62,881.40% | |
ev to operating cash flow | -0.31 - | 0.53 270.62% | -0.18 134.23% | -5.79 3,078.22% | -2.51 56.68% | 0.04 101.66% | -0.44 1,154.82% | -3.55 709.12% | -8.39 136.12% | -5.29K 63,007.44% | |
ev to sales | 0.16 - | -1.45 1,005.26% | 0.40 127.29% | 40.77 10,220.41% | 8.03 80.29% | -0.34 104.19% | 12.45 3,801.30% | 65.42 425.53% | 444.10 578.80% | 3.10M 698,864.00% | |
free cash flow per share | -247.26 - | -195.22 21.04% | -150.41 22.95% | -22.15 85.28% | -13.83 37.56% | -17.30 25.10% | -8.38 51.54% | -4.61 45.04% | -2.95 35.99% | -0.00 99.86% | |
free cash flow yield | -0.43 - | -1.16 168.11% | -2.00 72.55% | -0.14 92.93% | -0.30 114.94% | -2.40 689.68% | -0.51 78.79% | -0.23 54.27% | -0.10 56.68% | -0.00 99.81% | |
graham net net | 391.63 - | 242.71 38.02% | -17.03 107.02% | 26.94 258.19% | 24.17 10.28% | 5.94 75.41% | 32.73 450.61% | 15.21 53.52% | 11.88 21.89% | 0.01 99.92% | |
graham number | 3.25K - | 1.43K 55.97% | 200.48 86.00% | 118.14 41.07% | 98.50 16.62% | 58.70 40.41% | 153.92 162.23% | 48.59 68.43% | 32.91 32.27% | 0.03 99.90% | |
income quality | 0.28 - | 0.61 117.10% | 0.57 6.31% | 1.06 86.21% | 0.82 22.74% | 0.86 4.90% | 0.27 68.76% | 0.69 155.53% | 0.72 5.13% | 0.77 7.22% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -6.71 - | -79.34 1,081.96% | -131.66 65.95% | -69.27 47.39% | -37.90 45.29% | -50.27 32.66% | -217.28 332.20% | -26.58K 12,131.03% | -276.35 98.96% | 137.76 149.85% | |
interest debt per share | 110.01 - | 34.65 68.51% | 23.70 31.58% | 8.03 66.11% | 5.66 29.52% | 4.37 22.72% | 0.27 93.81% | 0.04 83.79% | 0.18 307.95% | 0.00 99.77% | |
inventory turnover | 18.12 - | 13.22 27.04% | 39.81 201.17% | ||||||||
invested capital | 0.01 - | 0.11 694.92% | -3.21 3,119.86% | 0.26 108.04% | 0.20 22.15% | 0.53 162.80% | 0.00 99.28% | 0.00 26.92% | 0.01 380.45% | 0.05 243.45% | |
market cap | 5.73M - | 6.05M 5.64% | 3.61M 40.29% | 200.72M 5,453.61% | 89.69M 55.32% | 15.04M 83.23% | 58.51M 289.01% | 235.63M 302.70% | 937.27M 297.77% | 974.77B 103,901.45% | |
net current asset value | 4.69M - | 9.24M 97.18% | -326K 103.53% | 37.90M 11,724.85% | 50.57M 33.43% | 15.23M 69.88% | 118.39M 677.32% | 184.17M 55.56% | 384.52M 108.79% | 438.08M 13.93% | |
net debt to ebitda | 0.74 - | 0.88 19.70% | 0.24 72.62% | 1.44 493.19% | 0.70 51.19% | 0.40 42.49% | 1.13 179.42% | 0.53 53.22% | 1.16 120.49% | 0.32 72.05% | |
net income per share | -786.95 - | -314.98 59.97% | -263.53 16.34% | -20.66 92.16% | -16.57 19.80% | -20.31 22.53% | -31.20 53.66% | -6.66 78.64% | -3.91 41.33% | -0.01 99.86% | |
operating cash flow per share | -220.73 - | -191.80 13.10% | -150.35 21.61% | -21.95 85.40% | -13.60 38.04% | -17.26 26.88% | -8.37 51.49% | -4.58 45.30% | -2.92 36.14% | -0.00 99.86% | |
payables turnover | 12.72 - | 10.21 19.68% | 16.03 56.88% | ||||||||
receivables turnover | 3.97 - | 6.44 62.23% | 6.37 1.14% | 2.75 56.83% | 349.42 12,609.23% | 41.31 88.18% | 6.57 - | 17.37 164.43% | |||
research and ddevelopement to revenue | 0.07 - | 0.39 482.09% | 0.27 32.60% | 4.90 1,742.14% | 3.63 26.00% | 7.80 115.01% | 26.96 245.61% | 19.20 28.78% | 56.94 196.57% | 508.81 793.61% | |
return on tangible assets | -0.98 - | -0.88 9.99% | -2.98 238.93% | -0.51 83.02% | -0.49 2.13% | -1.40 183.53% | -0.85 39.68% | -0.39 53.89% | -0.29 26.04% | -0.48 68.13% | |
revenue per share | 430.88 - | 70.57 83.62% | 69.38 1.68% | 3.12 95.50% | 4.25 36.20% | 2.14 49.75% | 0.30 86.18% | 0.25 15.78% | 0.06 77.79% | 0.00 99.99% | |
roe | -1.32 - | -1.09 17.37% | 38.88 3,672.68% | -0.69 101.77% | -0.64 7.48% | -2.69 322.75% | -0.92 65.66% | -0.42 54.24% | -0.32 24.95% | -0.54 69.38% | |
roic | -1.26 - | -0.97 22.97% | -17.53 1,704.07% | -0.55 96.86% | -0.56 1.37% | -1.77 217.19% | -0.91 48.25% | -0.42 53.83% | -0.32 23.40% | -0.55 70.14% | |
sales general and administrative to revenue | 1.63 - | 3.03 86.14% | 2.37 21.83% | 2.73 15.06% | 1.32 51.67% | 2.61 98.14% | 12.63 383.92% | 8.71 31.06% | 19.85 127.97% | 302.54 1,423.82% | |
shareholders equity per share | 597.55 - | 289.46 51.56% | -6.78 102.34% | 30.02 542.82% | 26.02 13.32% | 7.54 71.02% | 33.75 347.50% | 15.75 53.33% | 12.31 21.83% | 0.01 99.92% | |
stock based compensation to revenue | 0.99 - | 1.19 19.40% | 0.63 46.75% | 0.60 4.87% | 0.44 27.10% | 0.89 102.85% | 3.47 290.08% | 4.88 40.63% | 11.15 128.48% | 213.92 1,817.90% | |
tangible asset value | 5.99M - | 10.41M 73.76% | -326K 103.13% | 38.51M 11,912.88% | 51.34M 33.33% | 15.75M 69.32% | 120.04M 661.95% | 187.72M 56.38% | 395.06M 110.46% | 442.02M 11.89% | |
tangible book value per share | 597.55 - | 289.46 51.56% | -6.78 102.34% | 30.02 542.82% | 26.02 13.32% | 7.54 71.02% | 33.75 347.50% | 15.75 53.33% | 12.31 21.83% | 0.01 99.92% | |
working capital | 4.80M - | 9.27M 93.20% | -326K 103.52% | 47.97M 14,815.03% | 58.64M 22.23% | 19.56M 66.64% | 118.94M 508.09% | 186.53M 56.83% | 391.20M 109.73% | 459.84M 17.55% |
All numbers in USD (except ratios and percentages)